2 results
Approved WMOCompleted
- To compare the primary pharmacokinetic parameters AUC0-last, AUC0-*, and Cmax of MK-8228 after single dose administration of one tablet of 480 mg MK-8228 (test) and two tablets of 240 mg MK-8228 (reference) under fasting conditions.- To compare…
Approved WMOCompleted
This research project examines whether: -susceptibility to nocebo effects predicts future pain progression in patients with chronic widespread pain, i.e. fibromyalgia (part 1), - nocebo-related learning processes differ between patients and healthy…